Search

Calmare NJ USA

Tag

cancer pain

Medscape reports on another positive clinical trial using Calmare for cancer pain

medscapeAnother Calmare Therapy clinical trial, conducted with people battling neuropathic pain as a result of chemotherapy treatment, has again shown  positive patient outcomes (significant lessening of pain) according to a new report published this week by Medscape, an affiliate of WebMD. (You have to register to read the article, but the process is free, quick and easy).

clinical trialCalmare Trial Key Points / Excerpts:

  • Scrambler therapy was not originally developed for the treatment of cancer-related neuropathic pain. Rather, it was developed for chronic pain and, indeed, has been used in many patients with noncancer-related pain, including low back pain.
  • Regardless of the type of neuropathic pain being treated, scores on the 11-point Numerical Rating Scale (NRS) decreased significantly from baseline to 1-month follow-up (P < .001).
  • The need for ‘rescue opioids’ dropped from a baseline dose of 5 mg to 0 mg at the end of the study.
  • No adverse side effects (“events”) that could have been associated with the therapy were reported.
  • A research team from the Massey Cancer Center at Virginia Commonwealth University in Richmond reported similar findings using the same cutaneous electro-stimulation device (scrambler therapy) for CIPN (J Pain Symptom Manage. 2010;40:883-891).
  • Some patients relapsed, but re-treatment and maintenance therapy (booster treatments) provided relief and, again, no adverse effects from treatment were observed.
  • Charles Loprinzi, MD, PhD, from the Mayo Clinic in Rochester, Minnesota, and colleagues conducted a trial with 37 CIPN patients and achieved similar study outcomes (Support Care Cancer. 2015 23:943-951).
  • Dr. Loprinzi stated that people have been slow to explore scrambler therapy use because “it sounds too good to be true…” He also reported to Medscape that efforts to conduct larger trials are ongoing, but it takes time and money to perform these trials.

The European Journal of Oncology Nursing also published an abstract of the study reported by Medscape.


Cancer-related neuropathy affects 33% of cancer survivors

Chemotherapy is one of the most common (but powerful and often debilitating) treatments to combat several types of cancer. Thankfully, many patients survive as a result of this drug but thousands are left with chronic pain as a long-term side effect.

A new report states that a third of all cancer survivors experience long-term post-treatment pain after undergoing chemo:

CIPN_INFO Graphic

Calmare Pain Therapy Treatment received its initial FDA clearance as a treatment specifically for chemotherapy-induced peripheral neuropathy, or CIPN.

Here’s an account of a Calmare patient who came to us here in New Jersey from Europe to treat her ongoing post-chemo neuropathy.

Mayo Clinic has been engaged in Calmare scrambler clinical trials for the past two years. The Massey Cancer Center at VCU has also been engaged in fruitful research.

You can find another clinical trial/research performed by doctors and researchers at the Paul Carbone Cancer Center at the University of Wisconsin here https://calmaretherapynj.com/clinical-trials-2/u-of-wisconsin-madison-cipn/

Teaching hospitals using Calmare Therapy

The device is currently being used in the U.S. at these key teaching hospitals:

  • Virginia Commonwealth University’s Massey Cancer Center
  • Paul Carbone Cancer Center at University of Wisconsin-Madison

We talk with patients and families every day about pain

If you or a loved one is dealing with pain after chemotherapy treatment, you know how difficult it can be. Dr. Michael Cooney talks with patients and families every day about if / how Calmare scrambler therapy treatment may help lessen or even alleviate CIPN. Feel free to reach out to the Calmare NJ team.

Blog at WordPress.com.

Up ↑

%d bloggers like this: